Company intelligence / Profile preview

LI-COR Biosciences

Lincoln, Nebraska, United Stateslicor.com ↗

Ownership: Private
Employees: ~330
Development stage: Preclinical

Overview

LI-COR Biosciences is a global leader in designing and manufacturing innovative instruments, software, reagents, and integrated systems for environmental monitoring (e.g., photosynthesis measurement) and life science applications such as protein analysis (Western blots), DNA analysis/sequencing technology development. Its products are widely used by academic institutions and pharmaceutical companies worldwide.

Modalities: DeviceReagent
Industry: Agriculture & AgTech

Drug pipeline

2 assets

KH-4-43

Pre-clinical

Indications: Ovarian cancer

1 more asset in the full pipeline.

Request access →

Partnerships

Not specifically disclosed. The company collaborates broadly with academic institutions globally.

Beyond the preview

Go deeper on LI-COR Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LI-COR Biosciences.

Explore the full profile